CID 135451068

Tpo agonist 1

Structural Information

Molecular Formula
C25H22N8O2
SMILES
CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C5=NNN=N5)C
InChI
InChI=1S/C25H22N8O2/c1-14-10-11-19(12-15(14)2)33-25(35)22(16(3)30-33)27-26-21-9-5-8-20(23(21)34)17-6-4-7-18(13-17)24-28-31-32-29-24/h4-13,30,34H,1-3H3,(H,28,29,31,32)
InChIKey
YLSNQYHZCMCURB-UHFFFAOYSA-N
Compound name
2-(3,4-dimethylphenyl)-4-[[2-hydroxy-3-[3-(2H-tetrazol-5-yl)phenyl]phenyl]diazenyl]-5-methyl-1H-pyrazol-3-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

256
Patents

466.18658 Da
Monoisotopic Mass

5.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 467.19386 212.0
[M+Na]+ 489.17580 222.8
[M-H]- 465.17930 222.4
[M+NH4]+ 484.22040 214.4
[M+K]+ 505.14974 213.0
[M+H-H2O]+ 449.18384 199.0
[M+HCOO]- 511.18478 231.9
[M+CH3COO]- 525.20043 220.1
[M+Na-2H]- 487.16125 211.7
[M]+ 466.18603 214.4
[M]- 466.18713 214.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe